Trials / Completed
CompletedNCT05267769
Clinical Trial on Pharmacokinetics and Tolerability of AP707
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- CannaXan GmbH · Industry
- Sex
- Male
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Brief Summary:This study aims to investigate the uptake of AP707, a preparation from cannabis flowers, into the bloodstream after in single administration in healthy volunteers.
Detailed description
Pharmacokinetic parameters and tolerability of AP707 is studied over 24 hours after single dose administration in healthy volunteers in a prospective and open-label manner at a single study center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AP707 | Preparation of Cannabis flowers (Cannabis flos) |
Timeline
- Start date
- 2022-03-02
- Primary completion
- 2022-04-03
- Completion
- 2022-04-03
- First posted
- 2022-03-04
- Last updated
- 2022-07-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05267769. Inclusion in this directory is not an endorsement.